Zum Inhalt springen

Nur-Lesen-Fassung: Das Forschungsinformationssystem (FIS) ist aus Sicherheitsgründen vorübergehend durch diese Nur-Lesen-Fassung ersetzt. Alle öffentlichen Inhalte und Volltexte sind weiterhin abrufbar; Anmeldung, Bearbeitung, Einreichung und Statistiken stehen nicht zur Verfügung. Bei Fragen: fis@uni-bamberg.de

Start › Publikationen › Corporate social advocacy : medicine, placebo, or poison? : Opportunities and risks for companies and society – and communicative alternatives

Publikation

Corporate social advocacy : medicine, placebo, or poison? : Opportunities and risks for companies and society – and communicative alternatives

Hoffjann, Olaf (2025): Corporate social advocacy : medicine, placebo, or poison? : Opportunities and risks for companies and society – and communicative alternatives, in: Public Relations Journal, New York, NY [u.a.]: Public Relations Society of America, Jg. 18, Nr. 2, S. 1–29.

Details

Fakultät/Lehrstuhl
Autorin(nen)/Autor(en)
Titel der Zeitschrift
Public Relations Journal
ISSN
1942-4604
Verlagsangabe
Public Relations Society of America : New York, NY [u.a.]
Erscheinungsjahr
2025
Jahrgang
18
Heft
2
Sprache(n)
Englisch
URL
Abstract

In recent years, as societies have become increasingly polarized, companies have been positioning themselves on contemporary and controversial social issues ever more frequently. Over the last few years, there has been a boom in publications on corporate social advocacy (CSA) and in particular in (mostly experimental) stakeholder surveys. This is the starting point for this paper, which goes on to present a theoretical framework and outline practical implications. The paper first discusses the impact of CSA on companies and societal polarization based on existing studies and theoretical considerations (neo-institutionalism). It is clear that CSA appears to be at best a placebo for companies, as large companies with heterogeneous stakeholders in particular are likely to lose more supporters than they gain through such practices. For society, CSA is a poison because it further drives societal polarization. Therefore, companies are not only exacerbating the problems they sought to solve by using CSA, but are also increasingly having to justify their decision not to use CSA. Thus, it appears that it is high time CSA is brought to an end in the interests of both companies and society as a whole. Lastly, concrete alternatives and ways out are outlined. In essence: A medicine to counteract the poison of CSA is presented.

GND-Schlagwort(e)
Öffentlichkeitsarbeit
Freie Schlagwort(e)
corporate social advocacy
CEO activism
polarization
public relations
strategic communication
DDC-Klassifikation
070 Nachrichtenmedien, Journalismus, Verlagswesen
RVK-Klassifikation
AP 17420
Dokumenttyp
Artikel in einer Zeitschrift / Postprint
URI
Datum der Freischaltung
06.07.2026

Permalink: https://fis.uni-bamberg.de/handle/uniba/115950 · Daten als JSON · Zitieren: BibTeX · RIS

Datenstand: 15.11.2026

Eingeschränkter Lesezugriff: Anmeldung, Bearbeitung und Einreichung sind vorübergehend deaktiviert.